The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort

Abstract Background To compare the difference of postoperative anastomotic leakage (AL) rate between neoadjuvant chemoradiotherapy (NCRT) with pembrolizumab and NCRT group, and investigate the risk factors of developing AL for locally advanced esophageal squamous cell cancer (ESCC). Materials and me...

全面介紹

書目詳細資料

發表在:	BMC Cancer
Main Authors:	Wei-Xiang Qi, Shuyan Li, Huan Li, Jiayi Chen, Shengguang Zhao
格式:	Article
語言:	英语
出版:	BMC 2024-08-01
主題:	Esophageal squamous cell carcinoma Neoadjuvant chemoradiotherapy Pembrolizumab Anastomotic leakage Gastric fundus Nomogram
在線閱讀:	https://doi.org/10.1186/s12885-024-12774-w